<?xml version="1.0" encoding="UTF-8"?><template xmlns="openEHR/v1/Template" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><id>80162aa8-35c6-48ae-9c1c-900b17aa1b04</id><name>Remdesivir may prevent progression of mild-moderate symptomatic COVID if used within 7 days of symptom onset in patients with moderate-to-severe immun 408000271 Question</name><description><lifecycle_state>Initial</lifecycle_state><details><purpose/><use/><misuse/></details><other_details><item><key>MetaDataSet:Build</key><value>Build details</value></item><item><key>Acknowledgemet</key><value/></item><item><key>Analyst</key><value/></item><item><key>Attachments regarding build</key><value/></item><item><key>Build complete date</key><value/></item><item><key>Build team</key><value/></item><item><key>Comments</key><value/></item><item><key>Record name</key><value/></item><item><key>To ananlyst date</key><value/></item></other_details></description><annotations path="[openEHR-EHR-CLUSTER.freetextorderquestion.v1]"><items><item><key>Order Specific Questions.Question ID</key><value>&lt;p&gt;408000271&lt;/p&gt;</value></item><item><key>Order Specific Questions.Question Name</key><value>&lt;p&gt;AHS WIP REMDESIVIR MILD-MODERATE&lt;/p&gt;</value></item><item><key>Order Specific Questions.Question</key><value>&lt;p&gt;Remdesivir may prevent progression of mild-moderate symptomatic COVID if used within 7 days of symptom onset in patients with moderate-to-severe immunocompromise. Which moderately-to-severely immunocompromising condition does this patient have?&lt;/p&gt;</value></item><item><key>Technical.ï»© Technical Traceability</key><value>{~AHSID~80162aa8-35c6-48ae-9c1c-900b17aa1b04~NAME~Remdesivir may prevent progression of mild-moderate symptomatic COVID if used within 7 days of symptom onset in patients with moderate-to-severe immun 408000271 Question}</value></item></items></annotations><annotations path="[openEHR-EHR-CLUSTER.freetextorderquestion.v1]/items[at0001]"><items><item><key>Order Specific Questions.Answer Button Values</key><value>
						&lt;p&gt;Transplant&lt;/p&gt;
					
						&lt;p&gt;Treatment for hematologic malignancy&lt;/p&gt;
					
						&lt;p&gt;Anti-CD20 or B-cell depleting drug therapy in the past 2 years&lt;/p&gt;
					
						&lt;p&gt;Severe primary immunodeficiency&lt;/p&gt;
					
						&lt;p&gt;Treatment for cancer&lt;/p&gt;
					
						&lt;p&gt;Treatment with any biologic in the past 3 months&lt;/p&gt;
					
						&lt;p&gt;Treatment with an oral steroid (&amp;gt;20mg/day prednisone equivalent) in the past month&lt;/p&gt;
					
						&lt;p&gt;Advanced HIV (untreated or CD4 &amp;lt;200)&lt;/p&gt;
					
						&lt;p&gt;Moderate primary immunodeficiency&lt;/p&gt;
					
						&lt;p&gt;Renal dialysis, eGFR &amp;lt;15mL/min, or glomerulonephritis treated with steroids&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Comparison Operator</key><value>
						&lt;p&gt;1. Equals;Equals;Equals;Equals;Equals;Equals;Equals;Equals;Equals;Equals&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Condition Value</key><value>
						&lt;p&gt;1. Advanced HIV (untreated or CD4 &amp;lt;200);Anti-CD20 or B-cell depleting drug therapy in the past 2 years;Moderate primary immunodeficiency;Renal dialysis, eGFR &amp;lt;15mL/min, or glomerulonephritis treated with steroids;Severe primary immunodeficiency;Transplant;Treatment for cancer;Treatment for hematologic malignancy;Treatment with an oral steroid (&amp;gt;20mg/day prednisone equivalent) in the past month;Treatment with any biologic in the past 3 months&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Condition Comparison</key><value>
						&lt;p&gt;1. Or&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Questions</key><value>
						&lt;p&gt;1. 408000273&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Questions Record Name</key><value>
						&lt;p&gt;1. AHS WIP REMDESIVIR MILD-MODERATE CONTRAINDICATION TO PAXLOVID&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Hide Comments</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Multiple Comments and Duplicate Answers</key><value>&lt;p&gt;No&lt;/p&gt;</value></item><item><key>Order Specific Questions.Multiple Response</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Released Flag</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Require Response</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Response Type</key><value>&lt;p&gt;Custom List&lt;/p&gt;</value></item></items></annotations><definition xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1" concept_name="Freetextorderquestion" max="1" name="Remdesivir may prevent progression of mild-moderate symptomatic COVID if used within 7 days of symptom onset in patients with moderate-to-severe immunocompromise. Which moderately-to-severely immunocompromising condition does this patient have?"><Rule path="/items[at0001]"><constraint xsi:type="textConstraint"><includedValues>Transplant</includedValues><includedValues>Treatment for hematologic malignancy</includedValues><includedValues>Anti-CD20 or B-cell depleting drug therapy in the past 2 years</includedValues><includedValues>Severe primary immunodeficiency</includedValues><includedValues>Treatment for cancer</includedValues><includedValues>Treatment with any biologic in the past 3 months</includedValues><includedValues>Treatment with an oral steroid (&amp;gt;20mg/day prednisone equivalent) in the past month</includedValues><includedValues>Advanced HIV (untreated or CD4 &amp;lt;200)</includedValues><includedValues>Moderate primary immunodeficiency</includedValues><includedValues>Renal dialysis, eGFR &amp;lt;15mL/min, or glomerulonephritis treated with steroids</includedValues></constraint></Rule><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1" template_id="8a6bb5bf-ff20-476a-8ad5-51e657520e00" concept_name="Does the patient have an absolute contraindication to nirmatrelvir-ritonavir (Paxlovid) 408000273 Question" max="1" path="/items[at0002]" name="Does the patient have an absolute contraindication to nirmatrelvir-ritonavir (Paxlovid)?"/></definition><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1"><digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest></integrity_checks></template>